A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder

Lili Li1, Matthew Neil Bainbridge1, Yanli Tan1

  • 1From the Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, and Texas Heart Institute.

Circulation Research
|February 23, 2017
PubMed

Insights

Oligogenic inheritance, involving multiple genetic variants, may explain some cases of hypertrophic cardiomyopathy (HCM) where single-gene causes are not identified. These variants may not always strictly cosegregate with the disease phenotype.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition primarily linked to single-gene mutations in sarcomere proteins.
  • Approximately 40% of HCM cases lack identified causal genes, particularly in smaller families and sporadic instances where genetic cosegregation is difficult to establish.

Purpose of the Study:

  • To investigate the hypothesis that oligogenic inheritance, involving multiple genetic variants, contributes to the unexplained cases of HCM.
  • To determine if non-cosegregating pathogenic variants play a role in the genetic etiology of HCM.

Main Methods:

  • Whole exome sequencing was performed on a family trio affected by HCM.
  • Pathogenic variants were identified and analyzed for cosegregation with the HCM phenotype within the family.
  • Sanger sequencing was used for targeted genotyping of family members.

Main Results:

  • The family trio shared heterozygous pathogenic variants in TTN and ALPK3, genes associated with cardiomyopathy.
  • Affected siblings carried an additional pathogenic variant in MYL2, a known HCM gene.
  • The TTN variant showed cosegregation with HCM, but the ALPK3 variant did not consistently segregate with the phenotype across all affected individuals.

Conclusions:

  • A subset of hypertrophic cardiomyopathy cases may result from oligogenic inheritance.
  • Multiple pathogenic variants, not strictly cosegregating with the phenotype, could be responsible for some HCM cases.
  • This finding broadens the understanding of HCM's genetic architecture beyond single-gene mutations.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K